Prevalence of Hyperkalemia in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease: A Nested Case-Control Study

被引:33
|
作者
Loutradis, Charalampos [1 ]
Tolika, Panagiota [2 ]
Skodra, Alexandra [2 ]
Avdelidou, Afroditi [2 ]
Sarafidis, Pantelis A. [1 ]
机构
[1] Aristotle Univ Thessaloniki, Hippokrat Hosp, Dept Nephrol, Konstantinoupoleos 49, GR-54642 Thessaloniki, Greece
[2] Gen Hosp Grevena, Hemodialysis Unit, Grevena, Greece
关键词
Hyperkalemia; Diabetes; Chronic kidney disease; Angiotensin-converting enzyme inhibitors; GLOMERULAR-FILTRATION-RATE; POTASSIUM; HYPERTENSION; PREDICTORS; MELLITUS; BLOCKADE;
D O I
10.1159/000442393
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Hyperkalemia is a potentially life-threatening disorder, usually complicating chronic kidney disease (CKD). Factors superimposed to reduced renal function are further elevating hyperkalemia risk, but their contribution is not fully elucidated. This study aimed to compare the prevalence of hyperkalemia in diabetic and non-diabetic patients with CKD. Methods: This is a nested case-control study of 180 type-2 diabetic and 180 non-diabetic patients with CKD followed in a Nephrology outpatient clinic, matched for gender, age and estimated glomerular filtration rate. Type-1 diabetes or end-stage renal disease patients were excluded. Prevalence of hyperkalemia was defined as potassium >5 mEq/l or use of sodium polystyrene sulfonate, and further by potassium >5, >= 5.2 and >= 5.5 mEq/1. It was calculated in both groups in whole and CKD stages separately. Univariate and multivariate logistic regression analysis were conducted to identify factors associated with hyperkalemia. Results: The prevalence of hyperkalemia was higher in diabetic CKD patients (27.2 vs. 20%, p = 0.107) and remained around 30% higher with all secondary definitions used, but never reached statistical significance. In Stage 2, no difference was noted (8.7 vs. 17.4%, p = 0.665); in Stage 3, it was significantly higher in diabetics (28.6 vs. 17.5%, p = 0.036); and in Stage 4, it was equally high in both groups (35.5 vs. 32.3%, p = 0.788). In multivariate analysis, Stage 4 CKD (OR 4.535, 95% CI 1.561-13.173), use of angiotensin-converting enzyme inhibitors (ACEls; OR 2.228, 95% CI 1.254-3.958) and smoking (OR 2.254, 95% CI 1.218-4.171) were independently associated with hyperkalemia. Conclusions: Diabetes mellitus was found to elevate the prevalence of hyperkalemia only in CKD Stage 3 patients (moderately impaired renal function). Advanced CKD at Stage 4 and ACEIs are major determinants of hyperkalemia occurrence. (C) 2015 S. Karger AG, Basel
引用
收藏
页码:351 / 360
页数:10
相关论文
共 50 条
  • [21] Factors of microinflammation in non-diabetic chronic kidney disease: a pilot study
    Valerie Olivier
    Catherine Dunyach-Remy
    Pierre Corbeau
    Jean-Paul Cristol
    Thibault Sutra
    Stephane Burtey
    Jean-Philippe Lavigne
    Olivier Moranne
    BMC Nephrology, 21
  • [22] Characterizing predictors of non-diabetic kidney disease (NDKD) in diabetic patients
    Sana Shadab
    Parmod Mittal
    Adarsh Barwad
    Geetika Singh
    Arun Kumar Subbiah
    Raj Kanwar Yadav
    Sandeep Mahajan
    Dipankar Bhowmik
    Amit Dinda
    Sanjay Kumar Agarwal
    Soumita Bagchi
    International Urology and Nephrology, 2022, 54 : 1303 - 1309
  • [23] Characterizing predictors of non-diabetic kidney disease (NDKD) in diabetic patients
    Shadab, Sana
    Mittal, Parmod
    Barwad, Adarsh
    Singh, Geetika
    Subbiah, Arun Kumar
    Yadav, Raj Kanwar
    Mahajan, Sandeep
    Bhowmik, Dipankar
    Dinda, Amit
    Agarwal, Sanjay Kumar
    Bagchi, Soumita
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (06) : 1303 - 1309
  • [24] SGLT2 Inhibitors in Diabetic and Non-Diabetic Chronic Kidney Disease
    Podesta, Manuel Alfredo
    Sabiu, Gianmarco
    Galassi, Andrea
    Ciceri, Paola
    Cozzolino, Mario
    BIOMEDICINES, 2023, 11 (02)
  • [25] Evaluation of Cardiovascular Status with Non-Invasive Markers in Patients with Diabetic and Non-Diabetic Chronic Kidney Disease
    Karakose, Suleyman
    Guney, Ibrahim
    TURKISH JOURNAL OF NEPHROLOGY, 2020, 29 (03): : 221 - 225
  • [26] SERUM YKL-40 LEVEL AND ARTERIAL STIFFNESS IN NON-DIABETIC OBESE PATIENTS WITH CHRONIC KIDNEY DISEASE: A CASE CONTROL STUDY
    Tatar, Erhan
    Bozaci, Ilter
    Serel, Ali
    Mahser, Alev
    Bozkaya, Giray
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [27] Oral colonisation and infection by Candida sp in diabetic and non-diabetic patients with chronic kidney disease on dialysis
    de la Rosa-Garcia, Estela
    Miramontes-Zapata, Monica
    Sanchez-Vargas, Luis O.
    Mondragon-Padilla, Arnoldo
    NEFROLOGIA, 2013, 33 (06): : 764 - 770
  • [28] T-Cell Subpopulations and Differentiation Bias in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease
    Alacote, Ana Cecilia Granda
    Linares, Gabriela Goyoneche
    Torrico, Maria Gracia Castaneda
    Diaz-Obregon, Daysi Zulema
    Nunez, Michael Bryant Castro
    Carrasco, Alexis German Murillo
    Liendo, Cesar Liendo
    Goche, Katherine Susan Rufasto
    Correa, Victor Arrunategui
    Delgado, Joel de Leon
    BIOMEDICINES, 2025, 13 (01)
  • [29] Novel Risk Factors for Premature Peripheral Arterial Occlusive Disease in Non-Diabetic Patients: A Case-Control Study
    Berard, Annie M.
    Bedel, Aurelie
    Le Trequesser, Remi
    Freyburger, Genevieve
    Nurden, Alan
    Colomer, Sylvie
    Guerin, Viviane
    Vergnes, Marie-Christine
    Becker, Francois
    Camelot, Gabriel
    Bressolette, Luc
    Lacroix, Philippe
    Cambou, Jean-Pierre
    Bura-Riviere, Alessandra
    Emmerich, Joseph
    Darmon, Michel
    Deletraz, Anne-Marie
    Mesli, Samir
    Colombies, Brigitte
    Vanbrugghe, Virginie
    Conri, Claude
    Constans, Joel
    PLOS ONE, 2013, 8 (03):
  • [30] Oral mucosa and salivary findings in non-diabetic patients with chronic kidney disease
    Marinoski, Jovan
    Bokor-Bratic, Marija
    Mitic, Igor
    Cankovic, Milos
    ARCHIVES OF ORAL BIOLOGY, 2019, 102 : 205 - 211